🇺🇸 FDA
Patent

US 7273713

Methods of modulating mitochondrial NAD-dependent deacetylase

granted A61PA61P43/00

Quick answer

US patent 7273713 (Methods of modulating mitochondrial NAD-dependent deacetylase) held by The Regents of the University of California expires Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 25 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61P, A61P43/00